Related Experiment Video
Updated: Jul 4, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
P21 and p27: roles in carcinogenesis and drug resistance
Abde M Abukhdeir1, Ben Ho Park
1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Breast Cancer Research Program, Baltimore, MD, USA.
Abstract:
Human cancers arise from an imbalance of cell growth and cell death. Key proteins that govern this balance are those that mediate the cell cycle. Several different molecular effectors have been identified that tightly regulate specific phases of the cell cycle, including cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors. Notably, loss of expression or function of two G1-checkpoint CDK inhibitors - p21 (CDKN1A) and p27 (CDKN1B) - has been implicated in the genesis or progression of many human malignancies. Additionally, there is a growing body of evidence suggesting that functional loss of p21 or p27 can mediate a drug-resistance phenotype. However, reports in the literature have also suggested p21 and p27 can promote tumours, indicating a paradoxical effect. Here, we review historic and recent studies of these two CDK inhibitors, including their identification, function, importance to carcinogenesis and finally their roles in drug resistance.
Insights
This review examines cyclin-dependent kinase inhibitors p21 and p27, crucial for cell cycle regulation. Their loss is linked to cancer and drug resistance, though they can paradoxically promote tumors.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Human cancers result from dysregulated cell growth and death, governed by cell cycle proteins.
- Cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors are key regulators of the cell cycle.
- Loss of G1-checkpoint CDK inhibitors p21 (CDKN1A) and p27 (CDKN1B) is implicated in human malignancies.
Purpose of the Study:
- To review the identification and function of p21 and p27.
- To explore the roles of p21 and p27 in carcinogenesis.
- To analyze the involvement of p21 and p27 in drug resistance.
Main Methods:
- Literature review of historic and recent studies.
- Analysis of protein identification and function.
- Examination of roles in cancer development and drug resistance.
Main Results:
- Loss of p21 and p27 function is linked to cancer development and progression.
- Functional loss of p21 and p27 may confer a drug-resistance phenotype.
- Paradoxical evidence suggests p21 and p27 can also promote tumor growth.
Conclusions:
- p21 and p27 are critical regulators with complex roles in cell cycle control.
- Their dysregulation contributes to human carcinogenesis and impacts therapeutic outcomes.
- Understanding these dual roles is vital for cancer treatment strategies.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
